US Stock MarketDetailed Quotes

Windtree Therapeutics (WINT)

Watchlist
  • 0.0200
  • 0.00000.00%
15min DelayClose Jan 15 15:59 ET
586.68KMarket Cap-0.01P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Windtree Therapeutics (WINT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
1.13%-6.37M
-14.23%-2.66M
18.32%-2.41M
-14.62%-15.4M
-3.31%-3.69M
-67.20%-6.44M
33.49%-2.33M
-16.99%-2.95M
30.92%-13.44M
-5.53%-3.57M
Net income from continuing operations
-921.64%-28.09M
11.59%-10.63M
-139.58%-4.05M
91.19%-1.79M
153.69%2.77M
37.88%-2.75M
-82.15%-12.02M
348.58%10.22M
48.25%-20.29M
46.82%-5.15M
Operating gains losses
-312.96%-575K
2,335.65%7.71M
98.79%-178K
-281,633.33%-25.34M
-4,182.95%-10.53M
264.63%270K
-225.47%-345K
-70,238.10%-14.73M
101.30%9K
11.69%258K
Depreciation and amortization
1,614.29%360K
-29.17%17K
-19.05%17K
2.44%84K
106.27%18K
-80.91%21K
-89.83%24K
-8.70%21K
-84.62%82K
-1,295.83%-287K
Deferred tax
----
----
----
---210K
---210K
----
----
----
--0
----
Other non cash items
4,513.40%14.81M
-100.98%-80K
10.89%112K
2,022.49%8.68M
--86K
--321K
--8.17M
-12.93%101K
-22.54%409K
----
Change In working capital
-20.80%-2.82M
-29.68%1.2M
25.29%1.49M
-32.06%1.37M
-10.21%809K
-830.00%-2.34M
1,174.63%1.71M
79.49%1.19M
213.56%2.02M
208.29%901K
-Change in prepaid assets
99.39%-5K
-70.39%159K
38.15%373K
16.79%1.08M
126.88%1.09M
-363.02%-818K
724.42%537K
23.85%270K
-14.22%923K
23.39%480K
-Change in payables and accrued expense
-103.91%-2.45M
-14.31%1.1M
2.73%1.24M
102.88%1.27M
94.04%-23K
-1,144.35%-1.2M
295.69%1.29M
111.19%1.21M
127.43%626K
64.94%-386K
-Change in other current liabilities
-16.09%-368K
47.83%-60K
57.29%-123K
-308.32%-977K
-131.85%-257K
-199.06%-317K
-9.52%-115K
-126.77%-288K
182.14%469K
772.50%807K
Cash from discontinued investing activities
Operating cash flow
1.12%-6.37M
-14.23%-2.66M
18.32%-2.41M
-14.62%-15.4M
-3.31%-3.69M
-67.20%-6.44M
33.49%-2.33M
-16.99%-2.95M
30.92%-13.44M
-5.53%-3.57M
Investing cash flow
Cash flow from continuing investing activities
-789K
20.00%-12K
0
0
-107.61%-15K
0
Net PPE purchase and sale
--0
----
----
20.00%-12K
--0
--0
----
----
-107.61%-15K
--0
Net investment purchase and sale
---789K
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
---789K
----
----
20.00%-12K
--0
--0
----
----
-107.61%-15K
--0
Financing cash flow
Cash flow from continuing financing activities
1.76%7.06M
337.20%6.97M
74.18%1.8M
9.81%12.73M
507.29%3.16M
3,078.97%6.94M
-85.13%1.59M
74.96%1.03M
276.58%11.6M
-53.32%521K
Net issuance payments of debt
-744.44%-2.2M
123.59%3.72M
136.05%84K
257.72%1.26M
138.03%89K
-12.02%-261K
2,230.77%1.66M
7.54%-233K
32.11%-797K
37.93%-234K
Net common stock issuance
91.04%15.85M
--0
--0
-52.50%5.49M
-653.25%-4.18M
--8.3M
--0
--1.37M
171.55%11.55M
-49.43%755K
Net preferred stock issuance
-396.46%-4.21M
--2.81M
---483K
---1.88M
---1.03M
---847K
--0
--0
--0
--0
Cash dividends paid
--0
--0
---90K
---657K
---310K
---347K
--0
--0
--0
--0
Proceeds from stock option exercised by employees
--26K
--15K
--312K
--0
--0
--0
--0
--0
--843K
--0
Net other financing activities
----
725.00%425K
2,078.00%1.98M
--8.52M
--8.59M
--100K
---68K
---100K
----
----
Cash from discontinued financing activities
Financing cash flow
1.76%7.06M
337.20%6.97M
74.18%1.8M
9.81%12.73M
507.29%3.16M
3,078.97%6.94M
-85.13%1.59M
74.96%1.03M
276.58%11.6M
-53.32%521K
Net cash flow
Beginning cash position
-82.84%311K
-53.76%1.18M
-59.99%1.79M
-29.36%4.47M
-69.27%2.31M
-84.40%1.81M
-41.88%2.56M
-29.36%4.47M
-71.89%6.33M
-12.51%7.52M
Current changes in cash
-119.52%-97K
-17.07%-871K
68.32%-606K
-44.37%-2.68M
82.90%-521K
112.12%497K
-110.31%-744K
0.78%-1.91M
88.52%-1.86M
-34.54%-3.05M
End cash Position
-90.73%214K
-82.84%311K
-53.76%1.18M
-59.99%1.79M
-59.99%1.79M
-69.27%2.31M
-84.40%1.81M
-41.88%2.56M
-29.36%4.47M
-29.36%4.47M
Free cash flow
1.12%-6.37M
-13.64%-2.66M
18.32%-2.41M
-14.59%-15.41M
-3.31%-3.69M
-66.55%-6.44M
33.14%-2.34M
-16.99%-2.95M
30.89%-13.45M
-5.53%-3.57M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 1.13%-6.37M-14.23%-2.66M18.32%-2.41M-14.62%-15.4M-3.31%-3.69M-67.20%-6.44M33.49%-2.33M-16.99%-2.95M30.92%-13.44M-5.53%-3.57M
Net income from continuing operations -921.64%-28.09M11.59%-10.63M-139.58%-4.05M91.19%-1.79M153.69%2.77M37.88%-2.75M-82.15%-12.02M348.58%10.22M48.25%-20.29M46.82%-5.15M
Operating gains losses -312.96%-575K2,335.65%7.71M98.79%-178K-281,633.33%-25.34M-4,182.95%-10.53M264.63%270K-225.47%-345K-70,238.10%-14.73M101.30%9K11.69%258K
Depreciation and amortization 1,614.29%360K-29.17%17K-19.05%17K2.44%84K106.27%18K-80.91%21K-89.83%24K-8.70%21K-84.62%82K-1,295.83%-287K
Deferred tax ---------------210K---210K--------------0----
Other non cash items 4,513.40%14.81M-100.98%-80K10.89%112K2,022.49%8.68M--86K--321K--8.17M-12.93%101K-22.54%409K----
Change In working capital -20.80%-2.82M-29.68%1.2M25.29%1.49M-32.06%1.37M-10.21%809K-830.00%-2.34M1,174.63%1.71M79.49%1.19M213.56%2.02M208.29%901K
-Change in prepaid assets 99.39%-5K-70.39%159K38.15%373K16.79%1.08M126.88%1.09M-363.02%-818K724.42%537K23.85%270K-14.22%923K23.39%480K
-Change in payables and accrued expense -103.91%-2.45M-14.31%1.1M2.73%1.24M102.88%1.27M94.04%-23K-1,144.35%-1.2M295.69%1.29M111.19%1.21M127.43%626K64.94%-386K
-Change in other current liabilities -16.09%-368K47.83%-60K57.29%-123K-308.32%-977K-131.85%-257K-199.06%-317K-9.52%-115K-126.77%-288K182.14%469K772.50%807K
Cash from discontinued investing activities
Operating cash flow 1.12%-6.37M-14.23%-2.66M18.32%-2.41M-14.62%-15.4M-3.31%-3.69M-67.20%-6.44M33.49%-2.33M-16.99%-2.95M30.92%-13.44M-5.53%-3.57M
Investing cash flow
Cash flow from continuing investing activities -789K20.00%-12K00-107.61%-15K0
Net PPE purchase and sale --0--------20.00%-12K--0--0---------107.61%-15K--0
Net investment purchase and sale ---789K------------------0----------------
Cash from discontinued investing activities
Investing cash flow ---789K--------20.00%-12K--0--0---------107.61%-15K--0
Financing cash flow
Cash flow from continuing financing activities 1.76%7.06M337.20%6.97M74.18%1.8M9.81%12.73M507.29%3.16M3,078.97%6.94M-85.13%1.59M74.96%1.03M276.58%11.6M-53.32%521K
Net issuance payments of debt -744.44%-2.2M123.59%3.72M136.05%84K257.72%1.26M138.03%89K-12.02%-261K2,230.77%1.66M7.54%-233K32.11%-797K37.93%-234K
Net common stock issuance 91.04%15.85M--0--0-52.50%5.49M-653.25%-4.18M--8.3M--0--1.37M171.55%11.55M-49.43%755K
Net preferred stock issuance -396.46%-4.21M--2.81M---483K---1.88M---1.03M---847K--0--0--0--0
Cash dividends paid --0--0---90K---657K---310K---347K--0--0--0--0
Proceeds from stock option exercised by employees --26K--15K--312K--0--0--0--0--0--843K--0
Net other financing activities ----725.00%425K2,078.00%1.98M--8.52M--8.59M--100K---68K---100K--------
Cash from discontinued financing activities
Financing cash flow 1.76%7.06M337.20%6.97M74.18%1.8M9.81%12.73M507.29%3.16M3,078.97%6.94M-85.13%1.59M74.96%1.03M276.58%11.6M-53.32%521K
Net cash flow
Beginning cash position -82.84%311K-53.76%1.18M-59.99%1.79M-29.36%4.47M-69.27%2.31M-84.40%1.81M-41.88%2.56M-29.36%4.47M-71.89%6.33M-12.51%7.52M
Current changes in cash -119.52%-97K-17.07%-871K68.32%-606K-44.37%-2.68M82.90%-521K112.12%497K-110.31%-744K0.78%-1.91M88.52%-1.86M-34.54%-3.05M
End cash Position -90.73%214K-82.84%311K-53.76%1.18M-59.99%1.79M-59.99%1.79M-69.27%2.31M-84.40%1.81M-41.88%2.56M-29.36%4.47M-29.36%4.47M
Free cash flow 1.12%-6.37M-13.64%-2.66M18.32%-2.41M-14.59%-15.41M-3.31%-3.69M-66.55%-6.44M33.14%-2.34M-16.99%-2.95M30.89%-13.45M-5.53%-3.57M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -